Skip to content

A clinical research study investigating how the body processes the new compound petrelintide in people with kidney problems

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518124-77-00
Acronym
ZP8396-24059
Enrollment
48
Registered
2025-03-14
Start date
2025-03-26
Completion date
2025-11-25
Last updated
2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight management

Interventions

None listed

Sponsors

Zealand Pharma A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026